Skip to main content
Clinical Trials/IRCT20160307026950N35
IRCT20160307026950N35
Completed
Phase 3

Comparison of the effectiveness of two different doses of Dexmedetomidine on the prevention of nausea and vomiting in Discectomy under spinal anesthesia

Esfahan University of Medical Sciences0 sites135 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
ausea and vomiting due to Discectomy under spinal anesthesia.
Sponsor
Esfahan University of Medical Sciences
Enrollment
135
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients 18 to 60 years
  • Candidate for Discectomy under spinal anesthesia
  • Grade 1 and 2 Anesthesia Based on American Society Anesthesia Criteria

Exclusion Criteria

  • History of cardiovascular, respiratory, neurological, endocrine, thyroid, neuromuscular diseases, dysautonomia
  • Obesity (BMI\> 27\)
  • History of vasoactive drugs, MAOI and TCA
  • History of drug use
  • Allergy to Pethidine, Ketamine and Magnesium sulfate
  • Allergy to Dexmedetomidine
  • Taking drugs with drug interactions with Dexmedetomidine

Outcomes

Primary Outcomes

Not specified

Similar Trials